Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2005
12/15/2005CA2562940A1 Methods of promoting cardiac cell proliferation
12/15/2005CA2562771A1 Anti-il-9 antibody formulations and uses thereof
12/15/2005CA2562713A1 Phosphonate analogs of hiv integrase inhibitor compounds
12/15/2005CA2560472A1 Method for improved breast milk feeding to reduce the risk of allergy
12/14/2005EP1604953A1 Noble metal-magnetic metal oxide composite particle and method for producing same
12/14/2005EP1604687A1 Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer
12/14/2005EP1604684A1 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
12/14/2005EP1604683A2 Subcutaneously-administered ganglioside-based vaccine compositions
12/14/2005EP1604657A1 Pharmaceutical formulation of a stable Formoterol-containing solution for use in inhalation therapy and method of preparing it
12/14/2005EP1604652A2 Topical anaesthetic preparation for pretreatment for upper gastrointestinal endoscopy
12/14/2005EP1604650A2 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid
12/14/2005EP1604646A1 Viscous compositions containing carbon dioxide
12/14/2005EP1604645A1 Viscous compositions containing carbon dioxide
12/14/2005EP1603967A1 Multifunctional dendrimers and hyperbranched polymers as drug and gene delivery systems
12/14/2005EP1603950A2 Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
12/14/2005EP1603810A2 Package for and formulation of medicaments
12/14/2005EP1603607A2 Self-emulsifying compositions, methods of use and preparation
12/14/2005EP1603597A2 Oxycodone conjugates with lower abuse potential and extended duration of action
12/14/2005EP1603596A1 Liquid formulations of tumor necrosis factor-binding proteins
12/14/2005EP1603594A1 Pharmaceutical compositions of cell lysate and processes for the production and use thereof
12/14/2005EP1603589A1 Delivery system for drug and cell therapy
12/14/2005EP1603588A2 Stabilisation of growth hormones in solution
12/14/2005EP1603559A1 Pharmaceutical composition for intracellular acidification with cis-urocanic
12/14/2005EP1603541A2 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
12/14/2005EP1603537A2 A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained supression of gastric acid
12/14/2005EP1603531A2 Gel composition and method for treatment of vaginal infections
12/14/2005EP1603499A2 Invisible patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients onto the skin
12/14/2005EP1543324A4 Methods and compositions for grafting functional loops into a protein
12/14/2005EP1496902B1 Medicament containing steroids and a novel anticholinergic drug
12/14/2005EP1469938B1 Apparatus and process for preparing crystalline particles
12/14/2005EP1450786B1 Isoflavone concentrate and method for production thereof
12/14/2005EP1439847A4 Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
12/14/2005EP1416944B1 Composition for treatment of articular cartilage damage
12/14/2005EP1357870A4 Bioadhesive cell foam film of sustained-release delivery
12/14/2005EP1311296B1 Solution of an oxazolidinone antibiotic drug
12/14/2005EP1284771B1 Aerosol container for formulations of salmeterol xinafoate
12/14/2005EP1267880B1 Low dose entecavir formulation and use
12/14/2005EP1267803B1 Compositions and methods for treating hair loss using c16 - c20 aromatic tetrahydro prostaglandins
12/14/2005EP1261421B1 Skincare agents
12/14/2005EP1247526B1 Perfusion liquid preparations for ophthalmic operations
12/14/2005EP1217989B1 Vaccines for oral use which contain liposome-entrapped dna
12/14/2005EP1148870A4 Anti-plaque emulsions and products containing same
12/14/2005EP1121355B1 Quinoline derivatives and their use as antibacterial agents
12/14/2005EP1082103B1 Spill resistant pharmaceutical compositions
12/14/2005EP1043976B1 Oral pharmaceutical extended release dosage form
12/14/2005EP0927045B1 Tumor homing molecules, conjugates derived therefrom, and methods of using same
12/14/2005EP0765357B1 Antiviral dendrimers
12/14/2005CN1708540A High-molecular weight derivatives of camptothecins
12/14/2005CN1708514A Hydroxyalkyl starch derivatives
12/14/2005CN1708331A Formulations containing melatonin, ginkgo biloba, and biotin
12/14/2005CN1708301A Daily melatonin dosing units
12/14/2005CN1708295A Pharmaceutical solutions of modafinil compounds and use in preparation of medicine for treatment of diseases
12/14/2005CN1708283A Skin preparations for external use
12/14/2005CN1708270A Propofol with cysteine
12/14/2005CN1708269A Compositions and methods for transdermal oxybutynin therapy
12/14/2005CN1706865A Branched polyglycol-amino acid oligopeptide and its active derivative and medicinal composition
12/14/2005CN1706501A Prepn process of cyclodextrin inclusion for lipophilic medicine
12/14/2005CN1706500A Carrier suitable for gene delivery and its prepn process
12/14/2005CN1706499A Zine replenisher with palygorskite or mentmorillonite carrier and its prepn and usage
12/14/2005CN1231493C Amphoteric sterols and the use thereof
12/14/2005CN1231264C Liquid formulation comprising cetuximab and a fatty acid ester of polyoxyethylene sorbitan
12/14/2005CN1231256C Non-aqueous proton peptide formulations
12/14/2005CN1231219C Huangyangning slow-releasing preparation
12/14/2005CN1231218C Use of medicinal composition in preparing medicine for treating middle ear infections
12/14/2005CN1231208C Pharmaceutical compositions
12/13/2005US6974841 health and nutrition supplement for dogs; anti-oxidant vitamins, B complex vitamins, bioflavonoids, chelated minerals, digestive enzymes, nutrients and amino acids.
12/13/2005US6974832 L-ascorbic acid and pectin composition
12/13/2005US6974804 Suited to thickening or structuring a water-immiscible liquid, for example, a phase in a cosmetic formulation, such as antiperspirant or deodorant formulations, eg water in oil emulsions and especially translucent ones
12/13/2005US6974795 Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
12/13/2005US6974794 trolox bound to hemoglobin; biocompatible oxygen transporting molecules coupled with antioxidants; for protection of red blood cells (RBCs) against lysis.
12/13/2005US6974791 These peptides possess a charge motif of positive-positive-hydrophobic which is important in determining the specificity of binding to tumor-derived endothelium.
12/13/2005US6974699 Pharmaceuticals and assays using enzyme subunits
12/13/2005US6974595 Pharmaceutical compositions based on Diclofenae
12/13/2005US6974594 Method of preparing biological materials and preparations produced using same
12/13/2005US6974592 Exterior shell; drug delivery; storage stability
12/13/2005US6974591 Suspending a pore-forming agent in an aqueous dispersion of a film-forming, water insoluble polymer to form a coating suspension having solid particles of pore former suspended therein, and coating a drug-containing solid core, drying
12/13/2005US6974589 Neutral-cationic lipid for nucleic acid and drug delivery
12/13/2005US6974567 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque
12/13/2005US6973741 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
12/13/2005CA2442479C Topical compositions for prostaglandin e1 delivery
12/13/2005CA2435729C New film coating
12/13/2005CA2324403C Lipophilic microparticles containing a protein drug or antigen and formulation comprising same
12/13/2005CA2256596C Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid
12/13/2005CA2147274C Transdermal therapeutic system for administering physostigmin through the skin, and method of producing the system
12/11/2005CA2467769A1 Methods and formulations for testosterone suppression
12/08/2005WO2005116655A2 Natriuretic compounds, conjugates, and uses thereof
12/08/2005WO2005116255A2 Aptamer-toxin molecules and method for using same
12/08/2005WO2005116226A2 Nanoparticles comprising rna ligands
12/08/2005WO2005116068A1 Peptides or peptidic conjugate derivatives of msh and the use thereof for cosmetically fighting against canities
12/08/2005WO2005116067A2 Msh-agonist tripeptide conjugates
12/08/2005WO2005115477A2 Non-natural ribonuclease conjugates as cytotoxic agents
12/08/2005WO2005115475A1 Thickener for ophthalmic use
12/08/2005WO2005115474A1 Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
12/08/2005WO2005115473A2 Nutritional food and feed, composition, processing and method of use
12/08/2005WO2005115457A2 Combined active and passive targeting of biologically active agents
12/08/2005WO2005115443A1 Chronic articular inflammation-modulating composition based on collagen-polyvinylpyrrolidone
12/08/2005WO2005115441A2 Compositions and methods for enhanced mucosal delivery of parathyroid hormone
12/08/2005WO2005115418A2 New hydroxapatite calcium phosphates, their method of preparation and their applications
12/08/2005WO2005115417A2 Polycationic antimicrobial therapeutic
12/08/2005WO2005115387A1 Sustained release composition for oral administration of niacin
1 ... 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 ... 1712